Assignee
ENB THERAPEUTICS INC
US·6 granted patents·6 pending applications·19 citations·filing 2016–2024
Top patents by PatentIndex Score
12 records- 0192US11338014B2Methods and compositions for treatment of endothelin B receptor expressing tumorsENB THERAPEUTICS INC·Filed 2020·Granted May 24, 2022·3 cites·11 claims
- 0291US10695400B2Compositions and methods for treating cancers associated with ETBR activationENB THERAPEUTICS INC·Filed 2016·Granted Jun 30, 2020·6 cites·8 claims
- 0391US10435434B2Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activationENB THERAPEUTICS INC·Filed 2019·Granted Oct 8, 2019·5 cites·19 claims
- 0490US11066442B2Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activationENB THERAPEUTICS INC·Filed 2019·Granted Jul 20, 2021·4 cites·12 claims
- 0587US12077604B2Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activationENB THERAPEUTICS INC·Filed 2021·Granted Sep 3, 2024·1 cites·13 claims
- 0682US2024360173A1Deuterated compounds, compositions, and methods for treating cancers associated with etbr activationENB THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0774US12533390B2Methods and compositions for treatment of Endothelin B receptor expressing tumorsENB THERAPEUTICS INC·Filed 2022·Granted Jan 27, 2026·0 cites·11 claims
- 0860US2019314444A1Etbr antagonist compounds, compositions, and usesENB THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0959US2021077562A1Etbr antagonist compounds, compositions, and usesENB THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1049US2022265628A1Treatment of urothelial and kidney cancers by use of endothelin b receptor antagonistsENB THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1148US2020268829A1Methods and compositions for inhibiting metastases of an endothelin b receptor expressing cancerENB THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1248US2020289495A1Methods of inhibiting endothelin b receptor expressing tumor metastasesENB THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →